Effectiveness of Clozapine Versus Olanzapine for Treatment-Resistant Schizophrenia

This study has been terminated.
Sponsor:
Collaborators:
Dartmouth-Hitchcock Medical Center
Harvard Medical School
Commonwealth Research Center, Massachusetts
Eli Lilly and Company
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00169065
First received: September 10, 2005
Last updated: February 21, 2006
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given